Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses

Diabetic cardiomyopathy (DCM) is the principal cause of death in people with diabetes. However, there is currently no effective strategy to prevent the development of DCM. Although cyclovirobuxine D (CVB-D) has been widely used to treat multiple cardiovascular diseases, the possible beneficial effec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Jiang, Zhaohui, Fu, Lingyun, Xu, Yini, Hu, Xiaoxia, Yang, Hong, Zhang, Yanyan, Luo, Hong, Gan, Shiquan, Tao, Ling, Liang, Guiyou, Shen, Xiangchun
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7156511/
https://ncbi.nlm.nih.gov/pubmed/32286474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63498-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares